Ongoing support is available through the Omzo app and care team
We will help you achieve lasting results that go beyond weight loss and diabetes management
AEs leading to trial product discontinuation occurred in 51/603 (8.5%) participants in the CagriSema 2.4 mg/2.4 mg group, 40/605 (6.6%) participants in the semaglutide 2.4 mg group, 7/152 (4.6%) participants in the cagrilintide 2.4 mg group, 42/594 (7.1%) participants in the CagriSema 1 mg/1 mg group, 26/608 (4.3%) participants in the semaglutide 1 mg group, and 2/149 (1.3%) participants in the placebo group
Vallecillos starts patients on the lowest effective dose and gradually increases based on tolerance and response
Let's start by understanding exactly what allulose is, and I'll never forget when I first learned about this compound, because I saw it as an ingredient on, I think, some sort of Quest bar